SBSeyda Bilgin

Seyda Bilgin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seyda Bilgin has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Circulating biomarkers of the brain–muscle–metabolic axis in primary sarcopenia: neudesin, nesfatin-1, and irisin

    by Gulru Ulugerger Avci, Seyda Bilgin, Yunus Avci, Gunay Can, Ibrahim Murat Bolayirli, Deniz Suna Erdincler, Alper Doventas

  • Open Access

    Is primary sarcopenia more common in patients with restless legs syndrome?

    by Aysegul Akkan Suzan, Seyda Bilgin, Veysel Suzan

    This study aimed to investigate the frequency of primary sarcopenia in individuals with and without restless legs syndrome (RLS). In this cross-sectional study, 114 patients who presented to our outpatient clinic for the first time and were diagnosed with RLS and 147 patients without RLS were consecutively included. Patients with malignancy, uncontrolled diabetes mellitus, or diseases that may cause secondary sarcopenia or neuropathy were excluded from the study. The European Working Group on Sarcopenia in Older People 2 criteria for the diagnosis of sarcopenia and the International RLS Study Group criteria for the diagnosis of RLS were applied. The association between RLS and sarcopenia was analyzed using a logistic regression analysis. There were no significant differences in terms of chronic diseases. While there was no significant difference between the groups with and without RLS (70.11 ± 9.56 vs 71.76 ± 9.61) in terms of age ( P = .170), females were significantly higher in the RLS group ( P = .001). The rate of sarcopenia was significantly higher in patients with RLS (54% vs 37%, P = .005). In the multivariate logistic regression analysis of sarcopenia and sex (female), it was determined that both were associated with RLS [odds ratio 1.941 (95%) confidence interval 1.107–3.402, P = .021; odds ratio 2.733, (95%) confidence interval 1.442–5.177, P = .002], respectively). Primary sarcopenia is more common in patients with RLS than in those without RLS. Screening for sarcopenia should be considered in patients with restless leg syndrome.

  • Open Access

    The G8 tool for screening malnutrition before GLIM in geriatric cancer patients

    by Veysel Suzan, Damla Unal, Emir Celik, Bahar Bektan Kanat, Seyda Bilgin, Gulru Ulugerger Avci, Tugce Emiroglu Gedik, Rabia Bag Soytas, Oguzhan Cengiz, Nebi Serkan Demirci, et al.

    In our study, we examined the alignment of the G8 Geriatric Screening Tool with the Global Leadership Initiative on Malnutrition (GLIM) diagnostic criteria

  • Are nutrition and muscle strength impaired in Alzheimer's patients at an early stage?

    by Ayşegül Akkan Suzan, Seyda Bilgin, Tugce Nur Turkoglu, Veysel Suzan, Özlem Yılmaz

    Aim: The aim of our study is to compare early and mid-stage Alzheimer's disease patients and patients without Alzheimer's disease in terms of nutrition, muscle strength and frailty.Materials and Methods: Our study is a cross-sectional study conducted in the outpatient clinic of a tertiary health centre between 1 April and 1 December 2024. Alzheimer's disease was diagnosed according to the National Institute on Aging-Alzheimer's Association Working Groups criteria. According to the minimal status examination, 20-24 were considered mild and 10-19 were considered moderate dementia patients. MNA-SF (Mini Nutritional Assessment-Short Form) test for malnutrition, Handgrip strength (HGS) for muscle strength, FRAIL questionnaire for frailty were applied.Results: There was no significant difference between Alzheimer's disease patients (n=32; 20 early stage- 12 middle stage) and control patients without Alzheimer's disease (n=32) in terms of age and gender (p=0.279, p=0.768). MNA-SF and muscle strength were significantly lower in the Alzheimer's group compared to the control group (p=0.009, p

  • Open Access

    ChatGPT-4o in delirium recognition: a pilot study

    by Kubra Cingar Alpay, Suna Avci, Aysegul Gunduz, Duygu Ozata, Gokalp Kurthan Avlagı, Seyda Bilgin, Ummugulsum Durak, Alper Doventas, Deniz Suna Erdincler

    SUMMARY OBJECTIVE: Delirium is common yet frequently under-recognized in older adults and is associated with increased morbidity and mortality. Large language models may support clinical reasoning, but their performance and consistency in complex geriatric syndromes remain unclear. METHODS: We analyzed 20 PubMed-indexed geriatric case reports converted into structured vignettes with explicit references to delirium removed. ChatGPT-4o was tested in three conditions (two independent sessions and one consecutive-session run) to assess delirium identification and temporal consistency; DeepSeek-V2 served as a comparator. Two clinicians (geriatrician and neurologist) independently rated outputs for clinical plausibility, concordance with the reference diagnosis, and decision-support value. RESULTS: ChatGPT-4o identified delirium in 70% of cases in both independent sessions and 90% in the consecutive-session run, whereas DeepSeek-V2 identified 50%. Differences across ChatGPT-4o conditions were not significant (p=0.135). Agreement between independent ChatGPT-4o sessions was substantial (κ=0.76), while agreement involving the consecutive-session run was low, suggesting contextual priming. Expert ratings were higher in successfully identified cases across domains (all p<0.05). Inter-rater reliability was highest for concordance (Intraclass Correlation Coefficient=0.86). CONCLUSION: ChatGPT-4o showed promising but context-sensitive delirium recognition in geriatric vignettes. Large language models may serve as vigilance-enhancing decision-support tools under expert supervision, pending prospective validation.

  • What causes loss of muscle mass in primary sarcopenia: A MUNIX analysis and correlation with plasma biomarkers

    by Aysegul Akkan Suzan, Seyda Bilgin, Pelin Degirmenci, Nurten Uzun Adatepe, Alper Doventas, Aysegul Gunduz

    Introduction To determine if the loss of muscle mass in primary sarcopenia is secondary to motor neuron loss or directly related to muscle fiber loss using electrophysiological methods. Methods We recruited individuals with primary sarcopenia and non-sarcopenic individuals of similar age and gender for the study. After a detailed evaluation of geriatric syndromes and neurological disorders through systemic, neurological, and electrophysiological examinations, we recorded the motor unit number index (MUNIX) and motor unit size index (MUSIX) of the first dorsal interosseus (FDI) and tibialis anterior (TA) muscles in all participants. Results Individuals with sarcopenia exhibited reduced FDI MUNIX and lower TA CMAP amplitude and MUNIX values. The FDI MUNIX showed an inverse correlation with ferritin levels. Discussion Primary sarcopenia is characterized by motor unit loss without significant reinnervation. Motor unit loss in individuals with sarcopenia can be demonstrated in both the upper and lower extremities using the MUNIX method, and functional iron deficiency contributes to the etiology of primary sarcopenia. Conclusion Demonstration of motor unit loss in primary sarcopenia supports the hypothesis that the disease has a neuromuscular origin.


  • Open Access

    Association of Sleep Duration with Chronic Diseases and Geriatric Syndromes

    by Ayşegül Akkan Suzan, Seyda Bilgin, Veysel Suzan

    Background: It was aimed to investigate the relationship between sleep duration and chronic diseases and geriatric syndromes in geriatric patients. Materials and Methods: Our cross-sectional study included 174 patients admitted to the geriatric outpatient clinic for the first time between January 2024 and June 2024. Patients under 65 years of age, with active infection, terminal illness, diagnosis of malignancy, and history of trauma and infection in the last month were excluded from the study. In our study, in accordance with the recommendations of the ‘National Sleep Foundation’ and the ‘American Academy of Sleep Medi-cine (AASM)’, we considered sleep duration over 8 hours/day as long sleep in geriatric patients. Results: In our study, 107 geriatric patients with no long sleep duration (≤8 hours) and 67 geriatric patients with long sleep duration (˃8 hours) were included. There was no significant difference between the two groups in terms of age and gender (p=0.174, p=0.739). There was no significant difference between the two groups in terms of chronic diseases, number of chronic diseases and number of medications. Sarcopenia (%49 vs %33, p=0.046) and malnutrition (%35 vs %21, p=0.041) were found to be significantly higher in patients with longer sleep duration. There was no statistically significant difference between the two groups in terms of frailty, depression, cogni-tive status, basic and instrumental activities of daily living (p=0.208, p=0.062, p=0.097, p=0.110, p=0.117). Conclusions: Sarcopenia and malnutrition were observed at a higher rate in patients with long sleep duration. Based on this, sarcopenia and malnutrition screening should be emphasised in geriatric patients with long sleep duration.


  • Exploring the Relationship Between Primary Sarcopenia and Intestinal Barrier Dysfunction in Geriatric Patients: Insights from SARC-F, Serum DAO, Zonulin, LPS, and I-FABP Levels

    by Seyda Bilgin, Veysel Suzan, Bahar Bektan Kanat, Gulru Ulugerger Avci, Suna Avci, Hakan Yavuzer, Ibrahim Murat Bolayırlı, Alper Doventas, Deniz Suna Erdincler

    Introduction: The objective of this study is to assess the correlation between serum levels of DAO (Diamine oxidase), LPS (Lipopolysaccharide), I-FABP (Intestinal Fatty Acid Binding Protein), and Zonulin with primary sarcopenia in elderly patients, and to compare the diagnostic performance of these biomarkers with the SARC-F score. Methods: The study included 88 patients aged 65 and above. Comorbidities and geriatric syndromes were assessed, and those with secondary sarcopenia were excluded. The EWGSOP2 criteria were applied for diagnosing sarcopenia, while the SARC-F questionnaire was utilized to identify individuals at risk of sarcopenia. Serum levels of DAO, Zonulin, LPS, and I-FABP were measured using ELISA. Results: No significant differences were observed between the two groups regarding age and gender. SARC-F, serum DAO, and Zonulin concentrations were notably higher in the sarcopenia group than in the non-sarcopenia group (p<0.001). Statistically significant parameters were analyzed using stepwise multiple regression. In stepwise multivariate logistic regression analysis, both DAO and Zonulin scores were found to be associated with sarcopenia [Odds ratio (OR) 1.041, (95%) confidence interval (CI) 1.020-1.063, p<0.001; OR 1.108, (95%) CI 1.018-1.206, p=0.018, subsequently]. ROC curve analysis revealed that the area under the curve (AUC) for DAO, Zonulin, and SARC-F was 0.807 (p<0.001), 0.723 (p<0.001), and 0.943 (p<0.001), subsequently. The Spearman correlation test revealed a significant, low-correlation between serum Zonulin and the SARC-F score (r = 0.3583, p=0.0006), and a moderate-correlation between serum DAO and the SARC-F score (r = 0.4384, p<0.0001). Conclusion: This study is the first to show a connection between primary sarcopenia and intestinal barrier dysfunction. While the findings support the use of the SARC-F questionnaire in routine practice, serum levels of DAO and Zonulin could serve as an alternative when the SARC-F questionnaire is not applicable.


  • Open Access

    Insights into geriatric health: primary sarcopenia and innate immunity dynamics, examining SARC-F, serum TLR 4, TLR 9, and resolvin levels

    by Seyda Bilgin, Veysel Suzan, Suna Avci, Hakan Yavuzer, Ibrahim Murat Bolayirli, Alper Doventas, Deniz Suna Erdincler

    The aim of this study is to evaluate the relationship between serum TLR (Toll Like Receptor) 4, 9 and Resolvin E1 levels and primary sarcopenia in geriatric patients and to compare the diagnostic accuracy of these biomarkers with the SARC-F score. A total of 88 patients aged 65 years and older were evaluated in the study. Comorbidities and geriatric syndromes were identified and patients with secondary sarcopenia were excluded. EWGSOP2 criteria were used as diagnostic criteria for sarcopenia and SARC-F questionnaire was used to find individuals at risk for sarcopenia. Serum TLR 4, 9 and Resolvin E1 levels were analyzed by ELISA. There were no significant differences between the two groups in terms of age and gender (p = 0.654 and p = 1.000, respectively). SARC-F, serum TLR 9 and Resolvin E1 were significantly higher in the sarcopenia group compared to the non-sarcopenia group (p < 0.001, p < 0.001 and p = 0.040, respectively). Statistically significant parameters were evaluated by multiple regression analysis. TLR 9 and SARC-F score were both found to be associated with sarcopenia in multivariate logistic regression analysis [Odds ratio (OR) 3145, (95%) confidence interval (CI) 5.9–1,652,888.3, p = 0.012; OR 4.788, (95%) CI 2.148–10.672, p < 0.001, respectively]. ROC curve analysis showed that the area under the ROC curve (AUC) for TLR 9 and SARC-F was 0.896 (p < 0.001) and 0.943 (p < 0.001), respectively. Although this study supports the use of the SARC-F questionnaire in daily practice, serum TLR 9 levels may be an alternative to SARC-F in cases where SARC-F is not feasible.


  • FMF presented by aseptic abscesses

    by Seyda Bilgin, Serdal Uğurlu